The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy
Authors
Keywords
Myeloid-derived suppressor cells, Hepatocellular carcinoma, Radiation therapy, Overall survival
Journal
TUMOR BIOLOGY
Volume 37, Issue 8, Pages 10427-10433
Publisher
Springer Nature
Online
2016-02-05
DOI
10.1007/s13277-016-4916-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
- (2015) H.-M. Chen et al. CLINICAL CANCER RESEARCH
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
- (2015) Maria Napolitano et al. Oncotarget
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
- (2015) Oana Draghiciu et al. OncoImmunology
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
- (2013) S. Kalathil et al. CANCER RESEARCH
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- Increased Circulating Immunosuppressive CD14+HLA-DR−/Low Cells Correlate with Clinical Cancer Stage and Pathological Grade in Patients with Bladder Carcinoma
- (2013) X-K Yuan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
- (2013) Bin Zhang et al. PLoS One
- New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
- (2013) S. L. Liauw et al. Science Translational Medicine
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
- (2011) S. Solito et al. BLOOD
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid derived suppressor cells in human diseases
- (2011) Tim F. Greten et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma
- (2011) Tatsuya Yamashita et al. ONCOLOGY
- Radiation Therapy for Hepatocellular Carcinoma
- (2011) Mary Feng et al. SEMINARS IN RADIATION ONCOLOGY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?
- (2010) R. Lencioni et al. ONCOLOGIST
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started